NTA Publishes Survey on Preferences for Treatments for NPC Disease
On behalf of the Niemann-Pick Type C Therapy Accelerator (NTA) team, we would like to share with you a recent patient and caregiver survey in order to better understand the experiences of people with Niemann-Pick Type C (NPC) and their preferences for future treatments. This survey included questions about NPC symptoms, treatments, the impact of the disease on daily life, … Read More
- Page 2 of 2
- 1
- 2